Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SOMATROPIN for Neoplasm: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 9 adverse event reports in the FDA FAERS database where SOMATROPIN was used for Neoplasm.

Most Reported Side Effects for SOMATROPIN

Side Effect Reports % Deaths Hosp.
Drug dose omission by device 15,921 23.3% 5 92
Device leakage 9,113 13.3% 3 51
Device breakage 7,761 11.4% 2 54
Device mechanical issue 6,411 9.4% 1 28
Device information output issue 5,220 7.6% 1 16
Device issue 5,131 7.5% 2 69
Wrong technique in device usage process 4,746 6.9% 5 53
Injection site pain 4,009 5.9% 3 80
Poor quality device used 3,162 4.6% 1 23
Device use error 2,801 4.1% 1 15
Incorrect dose administered 2,772 4.1% 2 58
Device use issue 2,571 3.8% 1 19
Headache 2,545 3.7% 8 288
Incorrect dose administered by device 2,486 3.6% 3 27
Device physical property issue 2,449 3.6% 0 3

Other Indications for SOMATROPIN

Growth hormone deficiency (14,136) Product used for unknown indication (9,143) Hypopituitarism (5,842) Short stature (3,370) Dwarfism (1,411) Body height below normal (1,382) Turner's syndrome (1,239) Prader-willi syndrome (1,029) Growth retardation (944) Growth disorder (859)

Other Drugs Used for Neoplasm

BEVACIZUMAB (502) ATEZOLIZUMAB (404) CYCLOPHOSPHAMIDE (385) CARBOPLATIN (283) PACLITAXEL (267) NIVOLUMAB (219) OXALIPLATIN (185) PEMBROLIZUMAB (173) LENALIDOMIDE (171) DOXORUBICIN (150)

Related Pages

SOMATROPIN Full Profile All Neoplasm Drugs SOMATROPIN Demographics SOMATROPIN Timeline